WVU Cancer Institute’s Second Annual Lung Cancer Conference: Catalyzing Change to Address Lung Cancer

WVU Cancer Institute’s Second Annual Lung Cancer Conference: Catalyzing Change to Address Lung Cancer

Catalyzing Change to Address Lung Cancer Nov. 1-2

MORGANTOWN, W.Va. - Lung Cancer kills more West Virginians than breast, prostate, and colorectal cancers combined. On November 1-2, 2018, the WVU Cancer Institute and its partners, the Mountains of Hope Cancer Coalition and the Patient Advocate Foundation, will present the Second Annual Lung Cancer Conference: Catalyzing Change to Address Lung Cancer Nov. 1 and 2 at the WVU Erickson Alumni Center.

The free event is designed to heighten awareness about the impact of lung cancer across West Virginia. The conference will engage health care providers, health care delivery systems, community-based organizations, payers, advocates, public health educators, and policymakers to improve lung cancer screening, early detection, treatment, and survivorship.

The WVU Cancer Institute and its partners are excited to welcome Dr. Camara Jones who will present during both conference days. Dr. Jones is a Senior Fellow at Morehouse School of Medicine and a Past President of the American Public Health Association. Dr. Jones is a family physician and epidemiologist whose work focuses on broadening the national health debate to include universal access to high-quality healthcare with a focus on the social determinants of health, including poverty. Dr. Jones is a recognized expert in the public health community and is well-known for her creative allegories on race and racism.

Conference presenters also include faculty and clinicians from WVU; the vice chair of the Legislature’s Health and Human Services Committee; and a special guest from Harvard, Sarah Downer, JD. Sarah Downer is a Clinical Instructor at the Center for Health Law and Policy Innovation of Harvard Law School and directs the Center’s Whole Person Care Initiative, which seeks to improve care for underserved individuals at every point of interaction with the healthcare system. Downer will facilitate a discussion on the policy implications related to lung cancer in West Virginia.

Conference attendees will also participate in an interactive experience creating a unique graphic art installation based on discussions held during the meeting.

Scholarships are available for 20 health professionals, allied health professionals, community educators, or advocates to attend the conference. The award covers lodging for two nights and mileage reimbursement up to 250 miles. Deadline for submission is October 15, 2018.

For additional information, to apply for scholarships, and to register for the conference visit http://bit.ly/2NhyuzK.

  • WVU, partners announce regional hub to train entrepreneurs, commercialize healthcare technology

    WVU, partners announce regional hub to train entrepreneurs, commercialize healthcare technology

    Hoping to speed up the move from idea to application, West Virginia University and 23 other regional institutions have come together to create a “virtual hub” that will ultimately help speed the commercialization of groundbreaking university research. 

    Read More

  • Community-based research town hall

    WVCTSI and the WVU Mountaineer Health Initiative are co-sponsoring a town hall meeting to highlight research taking place across the state. “Conversation and Collaboration: WVU Community-Based Researchers and Outreach Staff Making a Difference,” offers attendees the chance to learn about the range of community engaged research and outreach across the state, meet colleagues engaged in similar work, identify common issues, and ascertain better ways to support each other in the field.

    Read More

  • Du Publishes Two Studies That Describe an Improved Approach to Bone Marrow Transplant

    Du Publishes Two Studies That Describe an Improved Approach to Bone Marrow Transplant

    WVU cancer researcher Wei Du, MD, PhD, teamed up with researchers from Cincinnati Children’s Hospital Medical Center to focus on improving outcomes and reducing side effects of traditional stem cell transplant. Their work was recently published in Leukemia, one of the top journals in hematology.

    Read More